Covered recipient · General Payments record
SUNIL JOHN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$3,357.71
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $781.55 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $287.93 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $124.71 | 1 |
| PFIZER INC. | $82.50 | 4 |
| Amgen Inc. | $78.30 | 4 |
| Janssen Biotech, Inc. | $71.77 | 1 |
| E.R. Squibb & Sons, L.L.C. | $62.99 | 3 |
| Lilly USA, LLC | $29.15 | 1 |
| Fresenius Kabi USA, LLC | $25.88 | 1 |
| SCILEX PHARMACEUTICALS INC. | $18.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.79 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999405 | CMS |
| ABBVIE INC. | $8.32 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999407 | CMS |
| ABBVIE INC. | $9.71 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999409 | CMS |
| ABBVIE INC. | $24.97 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999411 | CMS |
| ABBVIE INC. | $21.39 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999413 | CMS |
| ABBVIE INC. | $9.61 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999415 | CMS |
| ABBVIE INC. | $24.90 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999417 | CMS |
| ABBVIE INC. | $20.93 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999419 | CMS |
| ABBVIE INC. | $120.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999421 | CMS |
| ABBVIE INC. | $22.69 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999423 | CMS |
| ABBVIE INC. | $12.01 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999425 | CMS |
| Amgen Inc. | $18.55 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117589455 | CMS |
| Amgen Inc. | $27.62 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115768116 | CMS |
| Amgen Inc. | $17.17 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117589457 | CMS |
| Amgen Inc. | $14.96 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115768108 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.85 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101592599 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.04 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101592641 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.10 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101592671 | CMS |
| Fresenius Kabi USA, LLC | $25.88 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146945559 | CMS |
| Janssen Biotech, Inc. | $71.77 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078600948 | CMS |
| Lilly USA, LLC | $29.15 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135424085 | CMS |
| Novartis Pharmaceuticals Corporation | $124.71 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087153424 | CMS |
| PFIZER INC. | $29.41 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131675123 | CMS |
| PFIZER INC. | $16.72 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131863459 | CMS |
| PFIZER INC. | $14.49 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131960952 | CMS |
| PFIZER INC. | $21.88 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131194231 | CMS |
| SCILEX PHARMACEUTICALS INC. | $18.32 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136286275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.